Osman Celik to Imatinib Mesylate
This is a "connection" page, showing publications Osman Celik has written about Imatinib Mesylate.
Connection Strength
0.346
-
Outcome of COVID-19 in patients with chronic myeloid leukemia receiving tyrosine kinase inhibitors. J Oncol Pharm Pract. 2020 Oct; 26(7):1676-1682.
Score: 0.346
Connection Strength
The connection strength for concepts is the sum of the scores for each matching publication.
Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.